Scandinavian Real Heart AB (Publ)
Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis to fix the sternum after open-chest surgery. The company was founded in 1999 and is bas… Read more
Market Cap & Net Worth: Scandinavian Real Heart AB (Publ) (7820)
Scandinavian Real Heart AB (Publ) (F:7820) has a market capitalization of $5.82 Million (€5.67 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #31448 globally and #3497 in its home market, demonstrating a -3.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Scandinavian Real Heart AB (Publ)'s stock price €1.14 by its total outstanding shares 4998704 (5.00 Million).
Scandinavian Real Heart AB (Publ) Market Cap History: 2026 to 2026
Scandinavian Real Heart AB (Publ)'s market capitalization history from 2026 to 2026. Data shows growth from $5.82 Million to $5.82 Million (0.00% CAGR).
Scandinavian Real Heart AB (Publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Scandinavian Real Heart AB (Publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 7820 by Market Capitalization
Companies near Scandinavian Real Heart AB (Publ) in the global market cap rankings as of March 18, 2026.
Key companies related to Scandinavian Real Heart AB (Publ) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Scandinavian Real Heart AB (Publ) Historical Marketcap From 2026 to 2026
Between 2026 and today, Scandinavian Real Heart AB (Publ)'s market cap moved from $5.82 Million to $ 5.82 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €5.82 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Scandinavian Real Heart AB (Publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.82 Million USD |
| MoneyControl | $5.82 Million USD |
| MarketWatch | $5.82 Million USD |
| marketcap.company | $5.82 Million USD |
| Reuters | $5.82 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.